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This article describes a case study of trends of governance approach implementation in the health policy development 
and implementation process in Latvia, in the state in transition, or “new democracy”. Latvia became an independent 
democratic state in 1991, regaining its freedom after being part of the Soviet Union for 50 years. As the three Baltic 
States (Latvia, Lithuania, and Estonia) had a common history and starting point in the health reform implementation, 
the data of Human Immunodeficiency Virus (HIV) incidence and implemented policy steps were analyzed and 
compared of all the three states. The research provides insight into the HIV/Acquired Immune Deficiency Syndrome 
(AIDS) situation in Latvia from the time when the first patient was diagnosed till nowadays, describing the 
initiatives that were implemented to combat the spread of HIV infection and analyze the impact of different stakeholders 
in the policy development and implementation process. Although the main reform implementation actors in Latvia 
were Non-Governmental Organizations (NGOs) or patient organizations by performing cooperation and 
collaboration with all the actors involved in the policy development and implementation process, more profound 
investigation reveals that major impact came from “old democracies”, international and global organizations as well 
as from physicians and commercial powers by providing a suitable environment for the reform development. 
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Introduction 
The epidemic of Acquired Immune Deficiency Syndrome (AIDS) and the spread of Human 
Immunodeficiency Virus (HIV) infection are a worldwide problem for more than three decades, and according 
to the Joint United Nations Programme on HIV and AIDS (UNAIDS), the common goal for the whole world is 
to stop the AIDS epidemic by year 2030, by ensuring that everyone living with HIV has access to HIV 
treatment. The new formula or target that should be reached by 2020 is “90-90-90”, meaning that by the end of 
year 2020: 90% of all people living with HIV will know their HIV status, 90% of all people with diagnosed 
HIV infection will receive sustained antiretroviral treatment (ART), and 90% of all people receiving ART will 
have viral suppression (UNAIDS, 2017). 
HIV as an infectious disease has an impact on health and wellbeing of the whole society, and is not a 
national or even regional, but a global problem; so to combat the epidemic, activities have to be carried out 
globally. One of the indicators of the global significance of the HIV problem is establishment of the UNAIDS 
organization by the United Nations Economic and Social Council (ECOSOC) on 26 July, 1994 to undertake a 
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joint and cosponsored program on HIV on the basis of co-ownership, collaboration, planning and execution, 
and an equitable sharing of responsibilities with six cosponsoring United Nations organizations. UNAIDS still 
remains the only cosponsored joint program of the United Nations system and provides all levels of 
inclusiveness, providing multi-stakeholder approach with member states, cosponsors and civil society, and 
specifically people living with and affected by HIV1. 
To achieve the Goal 90-90-90 and combat the spread of HIV infection globally, all the member states 
should take actions and work in collaboration and cooperation with the civil sector and Non-Governmental 
Organizations (NGOs) on local levels providing good and smart governance. 
Latvia is a state in transition or a “new democracy”, located in the Baltic Region of Northern Europe. The 
state regained its freedom from the Soviet Union in year 1991, as did both the neighboring countries Estonia 
and Lithuania. Other countries that have borders with Latvia are Russia and Belarus. Latvia in year 2019 has 
1,919,968 inhabitants and its territory is 64,573 km2. Average life expectancy at birth for males is 70 years; for 
females is 79.6 years. The gross domestic product (GDP) in year 2018 was 29,523.664 million euros, per capita 
15,328 euros, and per employee 32,796 euros. Total expenditure of government in year 2017 was 10,220.064 
million euros and 37.806% of GDP, expenditure on health was 947.699 million euros or 3.506% of GDP or 
9.273% of total Government expenditure (CSB, 2019a; 2019b; 2019c; 2019d). 
Since March 29, 2004, Latvia is a member of the North Atlantic Treaty Organization (NATO) and since 
May 1, 2004, it is a member state of the European Union. Although the healthcare policy is the national 
competency of every member state of the European Union, HIV as an infectious disease is an influential factor 
to public health, and that is a part of the whole European Region policy. As Latvia is a partner and member in 
several unions and associations, it has obligations to work in cooperation and collaboration and under the 
collective policy to achieve global targets. 
The change that started in year 1991 by separating from the Union of Soviet Socialist Republics (USSR), 
initiated a global change in the way how health politics was organized: from centralized, planned economy 
health care system, to a new, comprehensive, and decentralized system. The implementation of new approaches 
in governing was stimulated by developed “old democracies” in other European countries, but hindered by the 
historical effects known as “path dependency” and “institutional inertia”. 
While in the “old democracies” in the middle of the 1990s, the second wave of governance―“Meta 
Governance” was reached, in the Baltic States, it was only a start of the first wave of governance―“Network 
Governance”. 
Shift from the old way of governing to a new approach, according to James A. Rhodes: “Governance 
signifies a change in the meaning of government, referring to new processes of governing; or changed 
conditions of the ordered rule; or new methods by which society is governed” (Rhodes, 2012, p. 33). The 
change implies not only a change in the processes and rules, but according to Levi-Faur, it also “includes a shift 
from politics to markets, from the community to markets, from politicians to experts, from political, economic, 
and social hierarchies to decentered markets, partnerships and networks” (Levi-Faur, 2012, p. 7). 
Change in the processes and environment requires also 
a paradigm shift from the old regulation by command and control to a regulatory governance model, signifying a 
collective intellectual and programmatic project for a new legal regime. New governance offers a vision of law and policy 
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that draws on the comparative strengths of both private and public stakeholders and highlights the multiple ways in which 
the various actors in society contribute to the acts of ordering social fields. (Lobel, 2012, p. 65) 
All the previously mentioned changes lead to the question: How these changes impact and change the role 
of the state in the process of reform or in the political change development and implementation process? The 
answer, provided by Guy Peters is: 
One can also conceptualize good governance as the existence of a state, operating alone or along with its partners that 
provide a wide range of services to the public. The logic is that the state should use its capacity to tax, spend, and regulate 
in order to improve the lives of citizens, a version of governance that clearly describes the welfare states of Europe. (Peters, 
2012, p. 26) 
Clarifying the meaning of governance in a health sector, according to the WHO definition “Governance is 
a political process that involves balancing and competing influences and demands” that is provided by “wide 
range of steering and rule-making related functions carried out by the government’s decision-makers as they 
seek to achieve national health policy objectives” (WHO, 2019). 
Narrowing the wide subject of health politics to HIV topic, the infectious disease that is not only a 
problem of the national, but also regional level, and which is influenced by a broad range of aspects, the role of 
cooperation and collaboration becomes even more significant and should be aimed to correspond to the WHO 
characteristics: “Beyond the formal health system, governance means collaborating with other sectors, 
including the private sector and civil society, to promote and maintain population health in a participatory and 
inclusive manner” and should be managed in that manner in either way―internally or locally as well as 
externally or globally (WHO, 2019). 
HIV/AIDS Patient in Latvia―25 Years Retrospective 
The first patient diagnosed with HIV in Latvia was in year 1987 and the HIV/AIDS Register was 
established in year 1994. According to data from the Register, on the 1st of July 2018, there were 5,500 patients 
in Latvia who were infected with HIV, but according to data from HIV specialists, the real figure of     
people infected with HIV in Latvia is for approximately one third higher (Latvijas Sabiedriskie Mediji [LSM], 
2018). 
According to the data from the Centre for Disease Prevention and Control of Latvia, in year 2018,   
newly diagnosed patients with HIV were 326 (221 male and 105 female). The distribution of transmission ways 
in year 2018 is as follows: The leading cause is heterosexual transmission (109), injection drugs (73), 
homosexual transmission (19), vertical transmission (5), and almost one-third of cases where the way of 
transmission was unknown (120). During the period of 1987-2018, patients diagnosed with HIV―7,669 (913 
of which are dead) and patients diagnosed with AIDS―2,036 (1,121 of which are dead) (SPKC, 2019a; 
2019b). 
The spread of infection prevalence is variable over time―starting to rise from year 1997, reaching its peak 
in year 2001, significantly decreasing in year 2005, and still rising again nowadays. During the whole period, 
dominating group of the patients is male (see Figure 1). 




Figure 1. HIV/AIDS diagnosed cases in Latvia (Source: SPKC, 2019a; 2019b). 
 
The way of transmission over time has significantly changed from homosexual transmission dominating at 
the start, to heterosexual transmission dominating at present; however, there is a significant part of patients with 
an unknown way of infection transition (see Figure 2). 
 
 
Figure 2. Way of HIV transition in diagnosed cases in Latvia (Source: SPKC, 2019a; 2019b). 
 
As can be observed from these data until year 1995, the increase in the number of patients diagnosed with 
HIV was relatively low, that is, 10 newly diagnosed cases with the leading way of transmission―homosexual 
and diagnosed mainly in male. 
The explosive increase in diagnosed cases was observed in year 2001, when the number of HIV diagnosed 
cases increased to 807 persons (626 male and 181 female) and the dominating way of transmission was 
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injecting drugs. In the next period of years 2002-2005, the number of diagnosed cases falls significantly to 299 
cases in year 2005, but still the main way of transition is drug injection. Only in year 2007, change in the way 
of infection transition is observable and dominating way becomes heterosexual. 
Comparing the data of HIV incidence with the neighboring countries―Lithuania, Estonia, Belarus, and 
Russia, there is a noticeable relation during the period of years 1996-2017, when the data show that the 
epidemic began in neighboring countries: from Russia in the East (rate 40.35 in year 2000 and 59.44 in year 
2001) and from Estonia in the North (rate 28.48 in year 2000 and 108.06 in year 2001), but staying relatively 
low in the South: Lithuania (rate 2.07 in year 2001 and peak of 11.44 in year 2002) with no significant impact 
on Belarus in the South-East. The epidemic started in the North with a dramatic impact on Estonia, presumably 
on the border with Russia (there is no public data available on the situation in Russia from year 2002 till year 
2010) and then spreading down to Latvia and Lithuania (see Figure 3). 
 
 
Figure 3. HIV incidence (Source: HIV/AIDS Surveillance in Europe, 2001; 2008; 2018). 
 
According to the data from the research in Estonia, the HIV epidemic started in the community of 
injecting drug users; as shown from cross-sectoral bio-behavioral studies and data from needle and syringe 
exchange programs conducted in year 2005, majority of HIV cases in Estonia have been diagnosed in the 
capital city―Tallinn (32 cases per 100,000 in year 2005) and in Ida-Viirum county in the North-Eastern part on 
the border with Russia (76 cases per 100,000, in year 2005 [NIHD Estonia, 2016]). 
The data about HIV incidence in the region as well as research in Estonia confirm that the HIV infection 
in this region started in Russia and afterwards spread through neighboring countries, thus once more confirming 
that infectious diseases are not only national, but also a regional problem and to overcome it, the activities have 
to be performed in cooperation and collaboration. 
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Comparing data of AIDS incidence with the neighboring countries during the long-time period of years 
1996-2017, Latvia was the country with the highest rate of cases almost for the whole period, when HIV was 
diagnosed at the AIDS phase (see Figure 4). 
 
 
Figure 4. AIDS incidence (Source: HIV/AIDS Surveillance in Europe, 2001; 2008; 2018). 
 
Despite the fact that the highest incidence of HIV was in Estonia reaching the rate of 108.06 cases while 
the highest rate in Latvia was three times lower (34.27), the highest rate of AIDS incidence was in Latvia, and 
is still the highest among neighboring countries. Those data of AIDS incidence lead to the conclusion that there 
is a lack of timely HIV diagnosis and treatment possibilities in Latvia. 
In comparison with other European countries in year 2017 where the average rate of HIV diagnosed 
patients was 6.2 per 100,000, in Latvia the rate was three times higher, reaching 18.8 per 100,000 people. In 
Latvia, there is not only the highest rate of newly diagnosed HIV patients in Europe, but also the average rate of 
AIDS patients 6.0 per 100,000, while in Europe 0.7 per 100,000 (European Centre for Disease Prevention and 
Control [ECDC], 2018). 
Research on HIV/AIDS policy development and implementation process in Latvia indicated that 
significant actors were Non-Governmental Organizations (NGOs), especially those who represented patients. 
The first NGO aimed to support persons with HIV/AIDS was established in year 1993, named Latvian for 
Support Group for People Living with HIV/AIDS (AGIHAS). Another NGO, established in year 2006, was 
“Apvienība.HIV”―the association that is working to improve the quality of life of people infected with HIV, in 
all its aspects involving advocacy as well as other forms of support. 
In year 2010, an international NGO “Baltic HIV Association” that united three Baltic States―Latvia, 
Lithuania, and Estonia was established. The NGO involves well-known specialists, former employees of United 
Nations Office on Drugs and Crime (UNODC), national AIDS center, and researchers. 
The main activities performed by NGOs were more focused on the provision of expertise in the HIV field 
by submitting recommendations to the Ministry of Health and other organizations. All three NGOs are still 
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actively working to protect the rights of the HIV/AIDS patients and to improve the quality of patients’ life and 
access to healthcare. 
One of the most significant factors for the HIV/AIDS patient treatment possibilities and to work on 
restricting the spread of infection in Latvia was due to the restrictions of possibilities to receive state-funded 
medication―Anti Retroviral Therapy (ART). 
At the beginning, the ART was provided only to patients if their immunity level; it is the number of 
Cluster of Differentiation 4 (CD4) cells was below 200. Although the UNAIDS recommended to abolish any 
restrictions depending on the immunity level of CD4 cells on receiving ART already in year 2015, due to 
scarce funding resources, these changes in Latvia were implemented only at the end of year 2018. In 
comparison to other developed countries, the state provided funding to healthcare needs is lower than 4% of 
GDP (aiming to reach 4% of GDP in 2020). The scarce resources impose limitations on possibilities to provide 
more funding to healthcare, especially for granting the funding to marginalized groups. 
Since July 1, 2016, the ART was provided to patients in Latvia if their rate of CD4 cells was below level 
350. Since January 1, 2018, if CD4 was below 500 and despite scarce resources and other obstacles, the goal 
was reached and since October 1, 2018, every patient diagnosed with HIV in Latvia can receive state-paid ART. 
How this was achieved is described in the section about NGO impact on policy development. In comparison 
with neighboring countries, in Estonia, restriction on CD4 count was abolished in 2016, in Lithuania in 
February 2018. 
A significant factor that was highlighted in discussions with the patient organizations in Latvia is the lack 
of specialists available in regions. There is only one hospital in Latvia where HIV/AIDS patients can receive 
consultations and prescriptions for medicine. For patients living in further regions from the capital Riga, 
especially for those who do not own a car, it is an obstacle to be a sympathetic patient and to follow all the 
treatment recommendations. That is a “hot topic” in Latvia, not only for HIV patients, but also for C-hepatitis 
and patients of other diseases. That is related to an insufficient number of specialists available in regions as 
well as to patients specific population density―in Riga, the capital of Latvia where half of all the population of 
Latvia is living. 
However, the most frightening factor for the HIV patient in Latvia is the high level of stigmatization and 
lack of knowledge about the disease and ways of its transmission in all parts of the society―also among 
medical specialists, especially the ones working in primary health care. 
According to first available research on society attitude to HIV infected people in the Baltic States, from 
the survey performed in Lithuania in year 2003 on public opinion about vulnerable groups, there is a significant 
increase in tolerance towards the people with HIV during the time. In year 1990, 77.6 percent of questioned 
people admitted having no wish to live in a neighborhood with people infected with HIV, in year 2003, this 
percentage was only 49.3 or 1.5 times less (Lithuanian AIDs Centre, 2004). 
The latest research on HIV Stigma index in the Baltic States was performed in Latvia in year 2018 by 
interviewing 409 HIV patients about their experience receiving health care services, attitude towards them in 
their workplaces and from their families, and friends. Research was also carried out on other aspects 
characterizing patients’ quality of life, social status, and self-stigmatization. According to the research results, 
due to a very high level of stigmatization in the society, 75.8% of patients are hiding their HIV diagnosis from 
others, 24.1% has decided to obtain from various social events, and 15% are isolating themselves from their 
families and friends (LETA, 2019). 
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Because of the HIV situation, most of the HIV patients feel various negative emotions: 50.5% feel 
ashamed, 47.2% feel guilty for having the HIV, 33.7% feel worthless, and 27.6% feel like being dirty (LETA, 
2019). The same research on Stigma index was performed in Estonia, already in year 2010. According to data 
from research in Estonia: Over 60% reported feeling guilty, 57% blamed themselves, 42% felt ashamed, and 
over 33% had low esteem (Estonian Network of People Living with HIV [ENPLHIV], 2012). Comparing 
results of the first Stigma index research in the Baltic States―performed in Estonia with the second research, 
made eight years later in Latvia, the level of stigma has decreased, but is still very high. 
According to research results on social life activities in year 2018, 12.2% of HIV patients in Latvia due to 
their HIV status decided not to have sex, 6.6% did not ask for medical help, 5.6% were not looking for social 
help, 5.4% decided not to apply for work, and 38% of HIV patients had experienced discrimination from medical 
specialists or family. Discrimination has been also observed on behalf of primary care specialists―17.1% of 
patients have experienced rumors from medical personnel, 8.2% received recommendations to discontinue their 
sexual life, and 6.7% noticed that information about their HIV status has been revealed to other persons without 
their permission. According to reproductive health research results, 6.6% of patients received recommendations 
not to have children and 15.8% females to interrupt their pregnancy, although using ART provide possibilities 
to give birth to healthy children (LETA, 2019). 
In the circumstances, there is enormous stigmatization from the society as well as self-stigmatization, 
lacking information about treatment possibilities and on options on how to live a quality life and stay an active 
member of society, while facing obstacles and misunderstandings in communication with healthcare 
professionals, the patient who have been diagnosed with HIV feels confused, abandoned, scared, and 
determined. 
During the last few years, a lot of initiatives to support and improve the lives of HIV patients were 
implemented. Apart from the change in the regulation of ART availability, a special national plan for 
HIV/AIDS and C-Hepatitis diagnostics and treatment has been developed and confirmed by the government at 
the end of year 2017, special programs of children nutrition have been implemented to support children born 
from HIV positive mothers, as well as a special program has been created to inform and support HIV patients. 
Of course, the situation for a patient diagnosed with HIV has been significantly changed and improved in 
comparison with the recent past, but there is still a lot of work to do to improve the possibilities for HIV 
patients in Latvia, to lead a quality life and enjoy one’s existence. In addition to current problems, new actual 
topics are developing―aging and HIV. That is a reality of today, as patients living with AIDS are becoming 70 
and older, and have multi-morbidity. 
NGO Impact on Policy Development and Implementation 
To get an inside view and explore how changes in the policy were achieved, the research was made on 
HIV/AIDS policy development and implementation process in Latvia. According to the research, all the 
previously mentioned results and implemented political initiatives in HIV related topics in Latvia were driven 
mainly by activities carried out by Non-Governmental Organizations (NGOs), especially patient organizations, 
with the leading player NGO “AGIHAS”. The activities that were carried out by this NGO had a significant 
impact on the society, the government and the Parliament, providing necessary pressure to the state institutions 
to make decisions and satisfy the demand of the society. 
AGIHAS was established in year 1993 with the aim that still after more than 25 years is the same: 
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The goal of the organization is to create throughout the region countries, life improvements and recognition of the 
rights of those affected by HIV/AIDS as well as to inform and educate the society, patients and those around them on the 
HIV infection, its risks and prevention tools, and finally increase adherence to HIV diagnostics, therapy and disease 
management. (AGIHAS, 2019) 
The most significant competence of the association that unites HIV patients is, as mentioned by the 
chairman of the board: “AGIHAS knows how it is to live with HIV and how it really feels, 
unlike―others―who only try to imagine, how it could be to live as HIV positive”. As the leaders of the NGO 
revealed, the success of the organization was not having some special strategy, long-middle and short term 
goals, neither plans nor projects, the whole 25 years, the organization was performing activities to combat the 
biggest problems that HIV patients have at that time. 
The first wave of activities at the end of the 1990s and the start of the millennium were focused on the 
people who were drug users and persons in places of imprisonment, as those were the places were situation was 
really dramatic. According to statistics, at that time, the dominating group infected by the HIV was men and the 
dominating ways of transmission were injecting drugs. The spread of infection among drug users rose 
dramatically starting from year 1997 when there were only five cases, reaching the top in year 2001 when 
infection was gained by intravenous drug usage in 666 cases (SPKC, 2019a; 2019b). 
Significant projects carried out by several NGOs (not only those―dedicated to HIV patients, but also 
others like “Red Cross”) with the aim to fight the spread of infection among intravenous drug users and to 
create special places where drug users could exchange used syringe and get sterile ones for free. As was 
mentioned in the articles, those places became very popular for drug users and those activities lead to a 
significant decrease of infection spread. 
Another smaller, but also an important activity was a project on elementary things―to give information to 
most vulnerable and hard to reach people by providing flyers and booklets about the infection transmission 
ways and giving free condoms―mainly in the places were drug users came to change syringes. Those projects 
of providing free exchange of used syringes are still active today and supported by many municipalities and 
now also partially funded by the state, as those projects exposed significant results. 
Similar activities were already earlier implemented in Estonia. HIV testing and counseling services to 
commercial sex workers have been provided since year 1994, needle and syringe exchange programs were 
initiated in year 1997 (Laisaar, Avi, DeHovitz, & Uuskula, 2011). 
In Lithuania, in year 1997, an anonymous counselling room for drug users was established offering needle 
exchange services that was sponsored by self-government of Klaipeda municipality and was the first of its kind 
in the Baltics. It took up the activities of needle and syringe exchange, condom distribution, dissemination of 
educational publications, and consulting on safer drug use and sexual behavior (Lithuanian AIDs Centre, 2004). 
Another NGO working mainly on topics about sexual education in adolescent groups in Latvia is 
“Papardes zieds”. It also carried out projects to educate youth about the HIV infection and safe sex as well as 
about other topics related to reproductive health. Those projects were not directly related to HIV infection, but 
knowledge about safe sex was also important to youth. Although those projects were successful, and even for 
some years, there was a special subject “health education” included in the school programs, after several years 
discussions arose in the society about the virtue and those topics were again excluded from the school programs. 
But there are still debates in the society on the topic, since after the changes made to raise a more virtue youth, 
the number of undesirable pregnancy cases in adolescence group increased. 
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When the first target audience―drug users were covered with the solution how to restrict infection among 
them, the second target group was identified at the start of the millennium was MSM (men having sex with 
men). That mostly happened in the places of imprisonment where those activities in most cases were not 
vulnerable. The projects carried out there were the same, providing flyers and booklets about the ways of 
infection transmission and by giving free condoms. 
When the first activities aimed to educate the society and limit the spread of infection were implemented 
and ran smoothly with great results, the next steps performed by NGOs were to consolidate community―the 
persons infected with HIV that was stigmatized groups and felled as pariahs. The NGOs created groups for 
self-support, in the places where HIV patients could come to talk to each other and feel like a social being. As 
most of the patients were not having any understanding or compassion and felt isolated by family, friends, and 
relatives, those became places where they could be themselves without wearing a mask. Even after many years 
and changes that have happened in the way how society refers to HIV patients, those support groups are still popular 
and required by the patients, especially after their first reaction―resistance phase and anger are gone, and the 
phase of acceptance of the state has set in and the patient is looking for information on how to live his life further. 
The idea of support groups, especially for patients who are recently diagnosed, was to help those patients 
to understand what the next steps are to be taken after the express test indicates that patient can be HIV positive. 
Support group provides persons who lead this new patient through the health care system, educate about how to 
live with HIV and how properly intake medicine, when and what tests should be made, monitor patients, assist, 
and support the patient. Those activities should provide increase in number of patients that are actively 
participating in the treatment process―use ART, regularly made tests and visits HIV specialist. After two years 
experience, when NGO came to the Ministry of Health of Latvia, and provided all the information―detailed 
reports on the program, activities and achieved results, the program was approved to be continued and funded 
by the state; starting from April 2019, this assistance program is a part of the state-run program and will be 
provided in even more places than before. 
The next step taken by NGOs was intended to provide better opportunities for children born from the 
mothers having HIV. As one of the ways of infection transmission is breastfeeding, the idea was to provide all 
those newborns with artificial nutrition. The project was developed in cooperation with the leading hospital in 
the capital of Latvia, Riga Maternity Hospital. In the first year, the nutrition was provided only in this one, the 
leading hospital; in the second year, having great program results and a lot of positive feedback, the sponsors of 
the project were ready to provide more funding and provide program also to all other hospitals were HIV 
positive mothers gave birth to babies which were supplied by nutrition instead of breath milk. After one and a 
half year, with reports on all of the results of the project―criterions, expenses, and outcomes presented to the 
Ministry of Health, as it was the period announces as dedicated to “Maternal and child health” and there were 
funding available from European Funds run under this program―this initiative also become state-provided 
project since July 2018 and is still running with great results. So, it is another example how the project 
developed and carried out by an NGO and funded by a non-state budget, with good results and being 
economically and socially effective and efficient, can become state-funded. Those few examples not only show 
how NGO initiatives can become state projects, but also demonstrate possibilities, knowledge, and expertise as 
well as leadership skills that NGOs have, but the state institutions in most cases did not have. 
However, the most valuable goal that has been reached as evaluated from both patient organizations and 
specialists was the development of “Action Plan for the Preventive of HIV, Sexually transmitted infections and 
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Hepatitis B and C for The 2018-2020 year” that was approved by the Cabinet of Ministers of Latvia on October 
31, 2017. 
All those achievements were reached by activities performed by NGOs, which were using all the tools and 
approaches that are described in Interest Group theory and Lobbying theory. For example, removal of the 
threshold was reached exerting pressure on decision-makers by organizing a campaign and publicly claiming 
Latvia to be the last state in the European Union having the limitation on access to ART for HIV patients as 
well as having a public discussion in the Ministry of Health and inviting UNAIDS ambassador to visit Latvia 
(the visit was organized by the NGO “AGIHAS”) to publicly speak and disgrace Latvia on this topic. 
Another initiative carried out by NGO “AGIHAS” in collaboration with other associations for several 
years is the conferences on international Worlds AIDS Day on December 1. These activities are great 
reminders of the existence of HIV/AIDS patients and impact of this infectious disease on the society, 
decision-makers included. 
According to action plan development, the great result was achieved working hand-in-hand with all the 
groups related to this topic: medical professional associations, patient NGOs, pharmacy, hospitals, and of 
course, the government institutions. According to the information from interviews, the process of action plan 
development was heavy and took quite a long time and countless hours spent in the search for compromises and 
best possible solution, acceptable by the majority of involved stakeholders. Although no one was completely 
satisfied with the result, in spite of scarce resources of funding, insufficient number of available specialists and 
the overall situation in healthcare sector in Latvia, the developed and approved action plan was a great 
achievement. 
Although when discussing activities and achieved results, the most significant actors are medical specialists, 
which knowledge, competence, and performing diagnosis and treatment, as well as patient organizations, of course, 
there are also some other power―players in the shadows or the pharmacy. Especially in the situation in Latvia, 
there are no special government funds provided to NGOs, and according to research results, the main supporters 
for NGOs, especially patient NGOs, are the pharmacy. In Latvia, there is a special regulation on activities that 
can be supported by drug manufacturers and that are prohibited, but the support of drug manufacturers, 
especially the global world known pharma companies have a significant role in supporting those NGOs. 
Another factor worth mentioning that provided possibilities for NGOs to achieve such great results was 
funding that was available in different cross-border programs as well as European Union Funds. NGOs were 
actively participating in program contests with their projects and significant part of NGOs projects were 
established by those foreign funds. There was also funding from local organizations that supported meaningful 
projects carried out by NGOs, for example, program on newborn nutrition was sponsored by the donations from 
two local organizations. 
Conclusions 
The research revealed that Non-Governmental Organizations (NGOs) and other interest groups have a 
significant impact on the society in the development towards a better democracy, by providing protection of the 
interests of marginal groups, especially in the case when those marginal groups are unwelcomed and 
stigmatized by the society. 
Research results confirm the widespread findings in the governance theory in “new democracies” were an 
active participatory society is developing, as written by Frank Fischer: 
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In many of the newly created participatory space activists have assisted excluded people―such as poor, women, 
AIDS victims, and the disabled―in developing a collective presence that has permitted them to speak for themselves. 
Through such efforts, activists and their citizen groups have in many cases succeeded in influencing the policies of 
mainstream institutions. (Fisher, 2012, p. 467) 
Another finding from the research was the lessons learned that good initiative with well-defined and 
achieved results that are reached by providing pilot projects and run by NGO can become a part of the 
state-funded and implemented policy afterwards. That can be explained by the knowledge, expertise, practice, 
and courage to deal with the risks and failures that interest groups or NGOs can afford, but the state lack, or 
cannot. 
According to the new approach of governing―governance, research on HIV/AIDS policy development, 
and implementation revealed that in Latvia, the “new democracy” state, there is a place for the society and the 
private sector to have an impact on the policy development and implementation, but unfortunately the good 
governance practice is not yet observed, since the state is not the leading actor in the policy development. In 
this case, the leading actor was the patients NGO, having enormous support from the medical service 
providers―physicians and pharmacies. 
Looking superficially at events described in this research report, it can be concluded, that the major and 
most visible actor in the change implementation were the patients organizations. However, according to 
theoretical findings by Yael Yishai (2012, p. 535), 
Patients influence is augmented when officials wish to introduce change and use health groups to support them in the 
face of professional opposition. Occasionally, patients are also drawn into partnerships with physicians to impede 
bureaucratic initiatives. Even under these circumstances patients do not exert influence on the policy process, but serve as 
cogs in the machine. 
Another aspect that is mentioned in the literature and was observable also in the case study in Latvia was as per 
Yishai “Health groups often depend on pharmaceutical companies for their organizational resources. The lack 
of independence and competition for funding also divides the patients’ movement, ultimately wreaking its 
impact and undermining its representation on a national level” (Yishai, 2012, p. 535). 
Although according to theory, patient organizations are not recognized as powerful actors, in the case 
report on HIV/AIDS policy in Latvia, patient organizations were the leaders, who actively initiated and 
tirelessly maintained cooperation and collaboration with all the stakeholders. According to interviews and 
public opinion on possibilities of NGOs, to have an impact on institutions as well as the trust in democracy and 
power to influence some processes is very low and is correlated to previous achievements and long-term 
recognition of the NGO. As the chairman of the association AGIHAS mentioned, the organization has become 
an actor who is invited in public decision making and collaboration with institutions only in the last few years, 
and not like before when for about 20 years they were not welcomed in the policy development process. 
A significant aspect that was observed during the research was the impact of other powerful players 
abroad. The most significant impact on decision-making arena environment was provided by the neighboring 
countries as well as international and global organizations. The new approach of governance provides that there 
is a developed civil society that supports and gives opportunities to interest group and NGO development. 
Therefore, another significant aspect of international institutionalism should be mentioned―the development of 
the civil society, which started in Latvia in year 2005, and the program provided to develop a powerful civil 
society was funded by the European Union and other foreign funding programs. So, we can conclude that there 
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is a significant impact of “old democracies” in “new democracies” in providing the way to new style of society 
governing―new governance approach. 
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